ReviewMolecular medicine reports2026
Role of PANoptosis in the development of gastric immunity and related gastric mucosal disease (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PANoptosis is a novel and unique form of programmed cell death associated with innate immune responses, which is primarily regulated by the aggregation and activation of the PANoptosome, and exhibits characteristics of apoptosis, pyroptosis and necroptosis. Therefore, the PANoptosome complex has become a key target for preventing this type of cell death. PANoptosis is considered to have a role in infectious diseases and cancer; however, to the best of our knowledge, its role in gastric mucosal diseases has not been comprehensively explored. With the advancement of research on the mechanisms underlying gastric mucosal diseases, a shared regulation and crosstalk among pyroptosis, apoptosis and necroptosis has been suggested to exist during the development and progression of these diseases. The present review briefly introduces the relevant mechanisms and features of PANoptosis, with a focus on its role in gastric mucosal diseases (such as acute gastric mucosal injury, infectious gastritis, autoimmune gastritis, spasmolytic polypeptide‑expressing metaplasia, gastric cancer and gastric‑associated lymphomas), with the aim of providing additional targets for the treatment of gastric mucosal diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.